EUVIMEDEUVIMED entdecken
Crossref

A Prospective Pathological Study to Refine Radiotherapy CTV Delineation for ESCC after Neoadjuvant Chemoimmunotherapy

H. Yin, G. Liang, J. Yang, Y. Wang, Y. Zhou, J. Ma, X. Wang

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e126-e127

DOI: 10.1016/j.ijrobp.2026.06.933 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von H. Yin und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yin, H., Liang, G., Yang, J., Wang, Y., Zhou, Y., Ma, J., & Wang, X. (2026). A Prospective Pathological Study to Refine Radiotherapy CTV Delineation for ESCC after Neoadjuvant Chemoimmunotherapy. International Journal of Radiation Oncology*Biology*Physics, 126(1), e126-e127. https://doi.org/10.1016/j.ijrobp.2026.06.933

Vancouver

Yin H, Liang G, Yang J, Wang Y, Zhou Y, Ma J, et al. A Prospective Pathological Study to Refine Radiotherapy CTV Delineation for ESCC after Neoadjuvant Chemoimmunotherapy. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e126-e127. doi:10.1016/j.ijrobp.2026.06.933

BibTeX
@article{Yin2026,
  author = {Yin, H. and Liang, G. and Yang, J. and Wang, Y. and Zhou, Y. and Ma, J. and Wang, X.},
  title = {A Prospective Pathological Study to Refine Radiotherapy CTV Delineation for ESCC after Neoadjuvant Chemoimmunotherapy},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {e126--e127},
  doi = {10.1016/j.ijrobp.2026.06.933}
}
Kostenlos starten →